Anixa Biosciences, Inc.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell te…

Biotechnology

US, San Jose [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Insiders

Form 3/4/5

Transactions

Download

Track non-derivative insider transactions.

i = Indirect d = Direct cs = Common Stock

Download

Reported Owner(s)	Position Now	Transaction Date	Type	Position Change	Extra
Titterton Lewis H Jr Director	$912,334 d cs 10% Holder	10/22/24	M	16,000 x $2.58 = $41,280.00	Footnotes Form 4 - Filed at 10/23/24
Titterton Lewis H Jr Director	$896,334 d cs 10% Holder	07/31/24	P	5,580 x $3.23 = $18,023.40	Footnotes Form 4 - Filed at 08/01/24
Titterton Lewis H Jr Director	$890,754 d cs 10% Holder	07/30/24	P	21,646 x $3.06 = $66,236.76	Footnotes Form 4 - Filed at 08/01/24
Titterton Lewis H Jr Director	$869,108 d cs 10% Holder	07/26/24	P	7,700 x $3.03 = $23,331.00	Footnotes Form 4 - Filed at 07/29/24
Baskies Arnold M Director	$115,000 d cs 10% Holder	07/26/24	P	5,000 x $3.09 = $15,450.00	Footnotes Form 4 - Filed at 07/26/24

Get PRO Today

With PRO you will unlock 32 more insider transactions for Anixa Biosciences, Inc.

Start Free 7-Day Trial Subscribe to PRO

Statistics

Sample Size: 37 Transactions

Sale (S)

11,800

2.70%

Buy (P)

173,065

51.35%

45.95%

Other Ownership

45.95%

Other Ownership

Individuals

We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:

Individuals

We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: